[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ECSP003654A - DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS - Google Patents

DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS

Info

Publication number
ECSP003654A
ECSP003654A ECSP003654A ECSP003654A EC SP003654 A ECSP003654 A EC SP003654A EC SP003654 A ECSP003654 A EC SP003654A EC SP003654 A ECSP003654 A EC SP003654A
Authority
EC
Ecuador
Prior art keywords
lipasa
inhibitors
formulations containing
dispersion formulations
dispersion
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Joseph Tardio
Paul Hadvary
Thomas Rades
Hans Lengsfeld
Hans Steffen
Smidt Passchier Christiaan De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003654 priority Critical patent/ECSP003654A/en
Publication of ECSP003654A publication Critical patent/ECSP003654A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El presente invento se refiere a composiciones farmacéuticas que comprende por lo menos un inhibidor de lipasas, de preferencia de lipasas gastro-intestinales y pancreáticas, por ejemplo orlistat, por lo menos un tensoactivo y por lo menos un dispersante.The present invention relates to pharmaceutical compositions comprising at least one lipase inhibitor, preferably gastro-intestinal and pancreatic lipases, for example orlistat, at least one surfactant and at least one dispersant.

ECSP003654 2000-09-13 2000-09-13 DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS ECSP003654A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003654 ECSP003654A (en) 2000-09-13 2000-09-13 DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003654 ECSP003654A (en) 2000-09-13 2000-09-13 DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS

Publications (1)

Publication Number Publication Date
ECSP003654A true ECSP003654A (en) 2001-04-23

Family

ID=42041253

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003654 ECSP003654A (en) 2000-09-13 2000-09-13 DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP003654A (en)

Similar Documents

Publication Publication Date Title
UY26338A1 (en) DISPERSIBLE FORMULATIONS CONTAINING LIPASE INHIBITORS
EE200200411A (en) Pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
BRPI0413363A (en) dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
UY32116A (en) A SOLID FORMULATION OF PHARMACEUTICAL DOSAGE
HK1049796B (en) Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
BG105967A (en) C(7) ester substituted taxanes and their use as antitumor agents
BR0113661A (en) Pharmaceutical compositions for the topical release of cyclooxygenase-2 enzyme inhibitors
TNSN07222A1 (en) Nematicidal compositions
TR200200635T2 (en) Aromatic esters for the labeling or labeling of petroleum products.
WO2002089788A3 (en) Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
AP1696A (en) Agrochemical formulations comprising ALS inhibitors.
WO2003057205A3 (en) Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs
NZ502133A (en) Method of enhancing bioavailability of fexofenadine and its derivatives
MXPA03002068A (en) Creatine ester pronutrient compounds and formulations.
ES2233695T3 (en) COMPOSITION THAT DELAYS THE GRID.
ECSP003654A (en) DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS
AR030593A1 (en) TENSIOACTIVE SYSTEM
NO20033921L (en) Monoamine uptake inhibitor
AU2001293944A1 (en) Method for sulphonylating a hydroxylated organic compound
PL351380A1 (en) C10 ester substituted taxanes as antitumor agents
FR2783518B1 (en) LTA4 HYDROLASE INHIBITORS
RS20050775A (en) A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor
WO2004012574A3 (en) Negative selections assays, and compositions thereof
HN2000000169A (en) GENE OF SRREPTIMYCES AVERMIITILIS THAT DIRECTS THE RELATIONSHIP OF AAVERMECTINES B2: B1
HN2000000084A (en) METALOPROTEASE INHIBITORS.